Pathologically, the c-Rel+ compared to the c-Rel− DLBCL group less frequently had Myc or pAKT overexpression, whereas more frequently expressed nuclear p50, p52 and RelB (Table 1). The gene discussed is CD40; the disease is diffuse large B-cell lymphoma.